References
- HalbertRJNatoliJLGanoABadamgaravEBuistASManninoDMGlobal burden of COPD: systematic review and meta-analysisEur Respir J200628352353216611654
- MathersCBoermaTFatDMThe Global Burden of Disease: 2004 UpdateGeneva, SwitzerlandWorld Health Organization2008
- National Heart Lung and Blood InstituteMorbidity and Mortaility: 2012 Chart Bood on Cardiovascular, Lung, and Blood Diseases2012 Available from: http://www.nhlbi.nih.gov/resources/docs/cht-book.htmAccessed August 1, 2013
- CamilliAERobbinsDRLebowitzMDDeath certificate reporting of confirmed airways obstructive diseaseAm J Epidemiol199113387958002021146
- DalalAAChristensenLLiuFRiedelAADirect costs of chronic obstructive pulmonary disease among managed care patientsInt J Chron Obstruct Pulmon Dis2010534134921037958
- HillemanDEDewanNMaleskerMFriedmanMPharmacoeconomic evaluation of COPD. 2000Chest2009136Suppl 5e3020162783
- StrasselsSASmithDHSullivanSDMahajanPSThe costs of treating COPD in the United StatesChest2001119234435211171708
- DonaldsonGCSeemungalTARBhowmikAWedzichaJARelationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary diseaseThorax2002571084785212324669
- SuissaSDell’anielloSErnstPLong-term natural history of chronic obstructive pulmonary disease: severe exacerbations and mortalityThorax2012671195796322684094
- JencksSFWilliamsMVColemanEARehospitalizations among patients in the Medicare fee-for-service programN Engl J Med2009360141418142819339721
- Medicare Payment Advisory CommissionReport to Congress: Promoting Greater Efficiency in Medicare2007 Available from: http://www.medpac.gov/documents/jun07_entirereport.pdfAccessed August 1, 2013
- United States CongressPatient Protection and Affordable Care Act2010 Available from: http://www.gpo.gov/fdsys/pkg/PLAW-111publ148/pdf/PLAW-111publ148.pdfAccessed August 1, 2013
- WilliamsMVA requirement to reduce readmissions: take care of the patient, not just the diseaseJAMA2013309439439623340642
- DharmarajanKHsiehAFLinZDiagnoses and timing of 30-day readmissions after hospitalization for heart failure, acute myocardial infarction, or pneumoniaJAMA2013309435536323340637
- BrockJMitchellJIrbyKAssociation between quality improvement for care transitions in communities and rehospitalizations among Medicare beneficiariesJAMA2013309438139123340640
- Global Initiative for Chronic Obstructive Lung DiseaseGlobal Strategy for the Diagnosis, Management, and Prevention of COPD (Updated 2013)2013 Available from: http://www.goldcopd.org/guidelines-global-strategy-for-diagnosis-management.htmlAccessed August 1, 2013
- FitchKIwasakiKPyensonBPlauschinatCZhangJVariation in adherence with Global Initiative for Chronic Obstructive Lung Disease (GOLD) drug therapy guidelines: a retrospective actuarial claims data analysisCurr Med Res Opin20112771425142921599554
- ShortPMLipworthSIWElderDHJSchembriSLipworthBJEffect of beta blockers in treatment of chronic obstructive pulmonary disease: a retrospective cohort studyBMJ2011342d254921558357
- GellerDEComparing clinical features of the nebulizer, metered-dose inhaler, and dry powder inhalerRespir Care200550101313132116185367
- DhandRDolovichMChippsBMyersTRRestrepoRFarrarJRThe role of nebulized therapy in the management of COPD: evidence and recommendationsCOPD201291587222292598
- United States CongressHealth Insurance Portability and Accountability Act of 19961996 Available from: http://www.gpo.gov/fdsys/pkg/PLAW-104publ191/html/PLAW-104publ191.htmAccessed September 19, 2012
- KirbySEDennisSMJayasingheUWHarrisMFPatient related factors in frequent readmissions: the influence of condition, access to services and patient choiceBMC Health Serv Res20101021620663141
- AverillRFGoldfieldNHughesJSAll Patient Refined Diagnosis Related Groups (APR-DRGs), Version 20.0: Methodology Overview2003 Available from: http://www.hcup-us.ahrq.govAccessed June 20, 2012
- RodrigoGJNanniniLJRodríguez-RoisinRSafety of long-acting beta-agonists in stable COPD: a systematic reviewChest200813351079108718460518
- BolluVKKarafilidisJColosiaABennettLHananiaNComparison of efficacy and safety outcomes in randomized trials of long-acting and short-acting β2-agonists for chronic obstructive pulmonary disease: a reviewJ Pulmon Resp Med201331137
- KiriVABettoncelliGTestiRViegiGInhaled corticosteroids are more effective in COPD patients when used with LABA than with SABARespir Med20059991115112415921904
- JhaAKTime to get serious about pay for performanceJAMA2013309434734823340633
- VaduganathanMBonowROGheorghiadeMThirty-day readmissions: the clock is tickingJAMA2013309434534623340632
- McCarthyDJohnsonMBAudetA-MRecasting readmissions by placing the hospital role in community contextJAMA2013309435135223340635
- LlorCMolinaJNaberanKCotsJMRosFMiravitllesMExacerbations worsen the quality of life of chronic obstructive pulmonary disease patients in primary health careInt J Clin Pract200862458559218266710